The 5-FU Holter Study

Recruiting now · Not applicable

Conditions studied: Gastrointestinal Malignancy

In brief

To assess the feasibility of using ambulatory ECG monitoring (Holter monitor) for patients receiving 5-FU chemotherapy

Key facts

Study ID

NCT06538610

Run by

University of Auckland, New Zealand

People needed

10

Starts

2024-11-01

Expected to finish

2026-01-01

Last updated by the study team

2024-12-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with diagnosis of gastrointestinal malignancy
• Planned to receive either FOLFOX chemotherapy with any treatment intent
• Aged ≥ 18 years at time of signing informed consent form

You may not qualify if…

• ECG with left bundle branch block or left ventricular hypertrophy with strain

Where it is running

• Auckland City Hospital — Auckland, New Zealand (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.